SE8007074L - GLUCAGON FRAGMENT THAN ITS USE - Google Patents

GLUCAGON FRAGMENT THAN ITS USE

Info

Publication number
SE8007074L
SE8007074L SE8007074A SE8007074A SE8007074L SE 8007074 L SE8007074 L SE 8007074L SE 8007074 A SE8007074 A SE 8007074A SE 8007074 A SE8007074 A SE 8007074A SE 8007074 L SE8007074 L SE 8007074L
Authority
SE
Sweden
Prior art keywords
glucagon
peptide
gln
conjugate
mammal
Prior art date
Application number
SE8007074A
Other languages
Unknown language ( )
Swedish (sv)
Inventor
N Nakagawa
K Kotani
K Ohyama
K Morita
S Katsuragi
T Noda
Original Assignee
Toyo Jozo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyo Jozo Kk filed Critical Toyo Jozo Kk
Publication of SE8007074L publication Critical patent/SE8007074L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

Known glucagon fragments are not effective in producing antibodies against glucagon but the problem has been overcome using the glucagon fragment (16-29) of formula [I]: H-Ser-Arg-Ala-Gln-Asp-Phe-Val- Gln-Trp-Leu-Met-Asn-Thr-OH which peptide may be conjugated with a protein such as albumin. The conjugate may be employed to prepare antibodies against the peptide of formula [I] by administering the conjugate to a mammal to sensitise the mammal to the peptide. The antibody is also active against glucagon (1-29) and therefore may be employed to determine glucagon (1-29) by contacting a glucagon- containing sample with the said antibody.
SE8007074A 1979-10-16 1980-10-09 GLUCAGON FRAGMENT THAN ITS USE SE8007074L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13406179A JPS5657753A (en) 1979-10-16 1979-10-16 Novel glucagon fragment, and its use

Publications (1)

Publication Number Publication Date
SE8007074L true SE8007074L (en) 1981-04-17

Family

ID=15119442

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8007074A SE8007074L (en) 1979-10-16 1980-10-09 GLUCAGON FRAGMENT THAN ITS USE

Country Status (6)

Country Link
JP (1) JPS5657753A (en)
DE (1) DE3039122A1 (en)
FR (1) FR2467841A1 (en)
GB (1) GB2062644B (en)
NL (1) NL8005703A (en)
SE (1) SE8007074L (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK283180A (en) * 1980-07-01 1982-01-02 Novo Industri As POLYPEPTIDES AND DERIVATIVES THEREOF
JPS5835155A (en) * 1981-08-24 1983-03-01 Otsuka Pharmaceut Co Ltd Peptide at terminal c of human lymphoblastoid interferon and its derivative
JPS5835156A (en) * 1981-08-24 1983-03-01 Otsuka Pharmaceut Co Ltd Fluorescent peptide and determination of human beta-interferon using the same
JPS5835157A (en) * 1981-08-24 1983-03-01 Otsuka Pharmaceut Co Ltd Lymphoblastoid interferon having peptide at terminal n and its derivative
JPS5835124A (en) * 1981-08-24 1983-03-01 Otsuka Pharmaceut Co Ltd Preparation of antibody
JPS5835122A (en) * 1981-08-24 1983-03-01 Otsuka Pharmaceut Co Ltd Preparation of antigen
JPS5835125A (en) * 1982-03-26 1983-03-01 Otsuka Pharmaceut Co Ltd Preparation of human alpha-interferon antibody
JPS5835123A (en) * 1982-03-26 1983-03-01 Otsuka Pharmaceut Co Ltd Preparation of human alpha-interferon antibody
JPS59122446A (en) * 1982-12-28 1984-07-14 Otsuka Pharmaceut Co Ltd Peptide relating to gamma-interferon
GB8322115D0 (en) * 1983-08-17 1983-09-21 Wellcome Found Physiologically active compositions
GB2160312B (en) * 1984-04-13 1987-09-16 South African Inventions Adjuvant for immunisation
DE9319125U1 (en) * 1993-12-13 1994-02-24 Bulldog Beratung Connecting element for connecting a wooden component to a second component
WO2019197313A1 (en) 2018-04-09 2019-10-17 Svar Life Science Ab Glucagon Assay

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1643345C3 (en) * 1967-08-19 1975-09-25 Hoechst Ag, 6000 Frankfurt Glucagon derivative and process for producing glucagon
JPS5836308B2 (en) * 1977-02-10 1983-08-08 大塚製薬株式会社 Antibody production method
US4206199A (en) * 1977-07-22 1980-06-03 Takeda Chemical Industries, Ltd. Novel glucagon fragment and its derivatives
JPS5424868A (en) * 1977-07-22 1979-02-24 Takeda Chem Ind Ltd Novel glucagon fragment
JPS5539702A (en) * 1978-08-30 1980-03-19 Takeda Chem Ind Ltd Method of measuring enzyme immunity of pancreas glucagon

Also Published As

Publication number Publication date
JPS5657753A (en) 1981-05-20
FR2467841A1 (en) 1981-04-30
GB2062644B (en) 1983-04-07
DE3039122A1 (en) 1981-04-30
GB2062644A (en) 1981-05-28
FR2467841B1 (en) 1984-10-19
NL8005703A (en) 1981-04-22

Similar Documents

Publication Publication Date Title
US5364837A (en) Method of modifying serum hormone levels using purified inhibin materials
SE8007074L (en) GLUCAGON FRAGMENT THAN ITS USE
BR9702179A (en) Conjugated process for treating a disease in a mammal and pharmaceutical composition
ATE112687T1 (en) MUTANTS OF HIV-1 ENVELOPE PROTEIN WITH MISSING HYPERVARIABLE DOMAINS.
FI932561A (en) Protein with intact epithelium and pharyngeal protein
BR9710811A (en) Antigen-binding fragments that specifically detect nucleotide cancer cells that encode the fragments and their use for the prophylaxis and detection of cancer
SE8202012L (en) HUMAN INTERFERON-RELATED PEPTIDES, ANTIGENS, ANTIBODIES AND PROCEDURES FOR PRODUCING THEREOF
ATE120759T1 (en) ATRIAL SODIUM URETIC/VASODILIZING POLYPEPTIDES.
Anttila et al. Interleukin 1 immunoreactivity in sebaceous glands
FI902143A0 (en) HIV-PEPTIDER, ARTIFICIELLA HIV-ANTIGENER OCH IMMUNOBESTAEMNINGSFOERPACKNINGAR.
ATE92634T1 (en) PROCEDURE FOR THE DETERMINATION OF A PROTEIN ACCORDING TO THE PRINCIPLE OF FLUORESCENCE POLARIZATION IMMUNOASSAY.
EP0111216A3 (en) Method for enzyme immunoassay and peptide-enzyme conjugate, its lyophilizate, antibody and kit therefor
Graindorge et al. Radioimmunologic method for detection of antitubular basement membrane antibodies
Frangione et al. Intrachain disulphide bridges in immunoglobulin G heavy chains. The Fc fragment
NO900758D0 (en) PROCEDURE FOR THE PREPARATION OF HYBRID PROTEIN.
IT1141277B (en) SYNTHETIC POLYPEPTIDE ACTIVE AS AN ANTIGEN, AND PROCEDURE FOR ITS PREPARATION
DE69014300T2 (en) RADIOACTIVE MARKING OF PROTEINS.
SE8904007D0 (en) MONOCLONA ANTIBODIES AND DIAGNOSTIZATION METHOD
Tatarinov et al. Comparative immunochemical analysis of specific β-globulins of the “pregnancy zone” in humans and other mammals
SE8705137D0 (en) DIAGNOSTIC METHOD FOR PRIMARY BILIARY CIRRHOSIS AND ANTIBODIES SUITABLE TO BE USED IN CERTAIN VERSIONS OF THE METHOD
DE69012572T2 (en) MONOCLONAL ANTIBODY AGAINST ACETYLATED LYSINE WASTE IN RECOMBINANT RIND SOMATOTROPINE.
KR890009417A (en) Method for producing monoclonal antibody and method of using the same
Kim et al. Antigenic and size differences between somatic and testicular cytochromes c
AU6205290A (en) Method for the detection of analytes
GB1505751A (en) Antigonadotropin antibodies and methods of preparation and use

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8007074-1

Format of ref document f/p: F